The Design of Membrane-Controlled Transdermal Therapeutic Systems Containing Molsidomine

Masayuki Yamada, Yusuke Tanigawara

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

A basic investigation aimed at developing a membrane-controlled transdermal therapeutic system was carried out. The drug used was molsidomine with oleic acid and propylene glycol as the absorption enhancer and the vehicle, respectively. It was concluded that a microporous polyethylene membrane was most suitable for release control. A desirable pattern of the molsidomine plasma concentration versus time curve could be obtained by controlling the amounts of the three components, molsidomine, oleic acid, and propylene glycol in the device. Furthermore, the plasma concentration of molsidomine was well sustained by adding polyethyleneglycol 400 to the oleic acid-propylene glycol solution.

Original languageEnglish
Pages (from-to)3407-3412
Number of pages6
JournalChemical and Pharmaceutical Bulletin
Volume35
Issue number8
DOIs
Publication statusPublished - 1987 Jan 1
Externally publishedYes

Keywords

  • Keywords-molsidomine
  • controlled release
  • drug delivery system
  • microporous membrane
  • transdermal

ASJC Scopus subject areas

  • Chemistry(all)
  • Drug Discovery

Fingerprint Dive into the research topics of 'The Design of Membrane-Controlled Transdermal Therapeutic Systems Containing Molsidomine'. Together they form a unique fingerprint.

Cite this